{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:40:35Z","timestamp":1790030435836,"version":"4.0.1"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1097\/01.jcp.0000095340.32154.c6","type":"journal-article","created":{"date-parts":[[2003,11,18]],"date-time":"2003-11-18T07:31:58Z","timestamp":1069140718000},"page":"576-581","source":"Crossref","is-referenced-by-count":82,"title":["Multiple-Dose Administration of Ginkgo biloba Did Not Affect Cytochrome P-450 2D6 or 3A4 Activity in Normal Volunteers"],"prefix":"10.1097","volume":"23","author":[{"given":"John S.","family":"Markowitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Donovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lindsay DeVane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Sipkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth D.","family":"Chavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210128","first-page":"33","article-title":"The booming U.S. botanical market: A new overview.","volume":"44","author":"Brevoort","year":"1998","journal-title":"Herbalgram"},{"key":"R2-8-20210128","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1001\/jama.280.18.1569","article-title":"Trends in alternative medicine use in the United States,1990\u20131997: Results of a follow-up national study.","volume":"280","author":"Eisenberg","year":"1998","journal-title":"JAMA"},{"key":"R3-8-20210128","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1211\/0022357021778970","article-title":"Pharmaceutical quality of different Ginkgo biloba brands.","volume":"54","author":"Kressmann","year":"2002","journal-title":"J Pharm Pharmacol"},{"key":"R4-8-20210128","first-page":"668","article-title":"Ginkgo bilobaExtract: Mechanisms and Clinical Indications.","volume":"81","author":"Diamond","year":"2000","journal-title":"Arch Phys Med Rehabil"},{"key":"R5-8-20210128","first-page":"70","article-title":"Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications.","volume":"7","author":"McKenna","year":"2001","journal-title":"Altern Ther Health Med"},{"key":"R6-8-20210128","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2125.1992.tb05642.x","article-title":"Ginkgo bilobafor cerebral insufficiency.","volume":"34","author":"Kleijnen","year":"1992","journal-title":"Br J Clin Pharmacol"},{"key":"R8-8-20210128","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00007691-199608000-00014","article-title":"Drug-metabolizing enzymes and therapeutic drug monitoring in psychiatry.","volume":"18","author":"Brosen","year":"1996","journal-title":"Ther Drug Monit"},{"key":"R9-8-20210128","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1080\/004982598238859","article-title":"Human cytochrome P450s: selectivity and measurement in vitro.","volume":"28","author":"Smith","year":"1998","journal-title":"Xenobiotica"},{"key":"R10-8-20210128","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00004714-199806000-00015","article-title":"Alprazolam is another substrate for human cytochrome P450-3A isoforms.","volume":"18","author":"Venkatakrishnan","year":"1998","journal-title":"J Clin Psychopharmacol"},{"key":"R11-8-20210128","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1080\/004982599238173","article-title":"Biotransformation of alprazolam by members of the cytochrome P4503A isoforms.","volume":"29","author":"Gorski","year":"1999","journal-title":"Xenobiotica"},{"key":"R12-8-20210128","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/01213011-199912000-00007","article-title":"Simultaneous assessment of CYP3A4 and CYP1A2 activity in vitro with alprazolam and caffeine.","volume":"9","author":"Schmider","year":"1999","journal-title":"Pharmacogenetics"},{"key":"R13-8-20210128","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2165\/00003088-199324060-00003","article-title":"Clinical pharmacokinetics of alprazolam. Therapeutic implications.","volume":"24","author":"Greenblatt","year":"1993","journal-title":"Clin Pharmacokinet"},{"key":"R14-8-20210128","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0893-133X(97)00166-8","article-title":"Effect of carbamazepine on the single oral dose pharmacokinetics of alprazolam.","volume":"18","author":"Furukori","year":"1998","journal-title":"Neuropsychopharmacol"},{"key":"R15-8-20210128","first-page":"1076","article-title":"Ginkgo (Part 2): Clinical efficacy, dosage, and adverse effects.","volume":"33","author":"Chavez","year":"1998","journal-title":"Hosp Pharm"},{"key":"R16-8-20210128","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1211\/002235702199","article-title":"Influence of pharmaceutical quality on the bioavailability of active components from Ginkgo biloba preparations.","volume":"54","author":"Kressmann","year":"2002","journal-title":"J Pharm Pharmacol"},{"key":"R17-8-20210128","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/clpt.1985.235","article-title":"Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquin hydroxylation.","volume":"38","author":"Schmid","year":"1985","journal-title":"Clin Pharm Ther"},{"key":"R18-8-20210128","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/001872089103300105","article-title":"Cognitive factors and the use of over-the-counter medication organizers by arthritis patients.","volume":"33","author":"Park","year":"1991","journal-title":"Human Factors"},{"key":"R19-8-20210128","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0378-4347(97)00225-9","article-title":"Modified high-performance liquid chromatographic method to measure both dextromethorphan and proguanil for oxidative phenotyping.","volume":"696","author":"Hoskins","year":"1997","journal-title":"J Chromatogr B"},{"key":"R20-8-20210128","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0378-4347(00)83150-3","article-title":"Alprazolam, alpha-hydroxy and 4-hydroxyalprazolam analysis in plasma by high performance liquid chromatography.","volume":"430","author":"Miller","year":"1988","journal-title":"J Chromatogr B"},{"key":"R21-8-20210128","first-page":"165","article-title":"Effect of Ginkgo biloba on microsomal enzyme induction.","volume":"9","author":"Duche","year":"1989","journal-title":"Int J Clin Pharm"},{"key":"R22-8-20210128","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0009-9236(96)90001-6","article-title":"Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.","volume":"59","author":"Engel","year":"1996","journal-title":"Clin Pharm Ther"},{"key":"R23-8-20210128","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1067\/mcp.2002.126913","article-title":"Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans.","volume":"72","author":"Gurley","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"R24-8-20210128","first-page":"86","article-title":"An open trial of nifedipine-herb interactions with St. John\u2019s wort, ginseng, and ginkgo biloba.","volume":"69","author":"Smith","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"R25-8-20210128","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0944-7113(00)80044-6","article-title":"An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures.","volume":"74","author":"Budzinski","year":"2000","journal-title":"Phytomedicine"},{"key":"R26-8-20210128","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0024-3205(02)01913-6","article-title":"Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity.","volume":"71","author":"Zou","year":"2002","journal-title":"Life Sci"},{"key":"R27-8-20210128","first-page":"53","article-title":"The emerging recognition of herb-drug interactions with a focus on St. John\u2019s Wort (Hypericum perforatum).","volume":"35","author":"Markowitz","year":"2001","journal-title":"Psychopharmacol Bull"},{"key":"R28-8-20210128","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1067\/mcp.2000.105757","article-title":"Alprazolam-ritonavir interaction: Implications for product labeling.","volume":"67","author":"Greenblatt","year":"2000","journal-title":"Clin Pharm Ther"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.jcp.0000095340.32154.c6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:44:24Z","timestamp":1785768264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-200312000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003]]}},"URL":"https:\/\/doi.org\/10.1097\/01.jcp.0000095340.32154.c6","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}